USPTO Says VirnetX Can't Get Arthrex Do-Over On Network IP
The U.S. Patent and Trademark Office told the Federal Circuit Wednesday that VirnetX should not be able to invoke Arthrex to get rehearings on Patent Trial and Appeal Board rulings that...To view the full article, register now.
Already a subscriber? Click here to view full article